Johnson & Johnson Price to Book Ratio 2006-2021 | JNJ

Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of September 22, 2021 is 6.20.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Johnson & Johnson Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-09-22 163.93 6.20
2021-06-30 163.76 $26.44 6.19
2021-03-31 162.37 $25.01 6.49
2020-12-31 154.52 $24.04 6.43
2020-09-30 145.15 $24.49 5.93
2020-06-30 136.20 $23.92 5.69
2020-03-31 126.12 $23.28 5.42
2019-12-31 139.39 $22.59 6.17
2019-09-30 122.78 $22.13 5.55
2019-06-30 132.18 $23.01 5.75
2019-03-31 131.76 $22.20 5.94
2018-12-31 120.84 $22.44 5.38
2018-09-30 128.56 $24.09 5.34
2018-06-30 112.15 $23.45 4.78
2018-03-31 117.58 $23.58 4.99
2017-12-31 127.38 $22.43 5.68
2017-09-30 117.81 $27.55 4.28
2017-06-30 119.12 $26.78 4.45
2017-03-31 111.41 $26.10 4.27
2016-12-31 102.39 $26.02 3.94
2016-09-30 104.26 $26.73 3.90
2016-06-30 106.35 $26.47 4.02
2016-03-31 94.20 $26.40 3.57
2015-12-31 88.79 $25.82 3.44
2015-09-30 80.10 $25.86 3.10
2015-06-30 82.98 $25.69 3.23
2015-03-31 85.03 $24.45 3.48
2014-12-31 87.77 $25.06 3.50
2014-09-30 88.89 $27.31 3.25
2014-06-30 86.66 $27.65 3.13
2014-03-31 80.81 $27.08 2.98
2013-12-31 74.80 $26.25 2.85
2013-09-30 70.31 $24.75 2.84
2013-06-30 69.13 $24.75 2.79
2013-03-31 65.15 $23.85 2.73
2012-12-31 55.57 $23.33 2.38
2012-09-30 54.15 $23.08 2.35
2012-06-30 52.61 $21.97 2.39
2012-03-31 50.88 $22.35 2.28
2011-12-31 50.14 $20.95 2.39
2011-09-30 48.25 $22.52 2.14
2011-06-30 49.95 $22.67 2.20
2011-03-31 44.10 $21.86 2.02
2010-12-31 45.63 $20.66 2.21
2010-09-30 45.32 $20.85 2.17
2010-06-30 42.79 $19.19 2.23
2010-03-31 46.81 $19.19 2.44
2009-12-31 45.89 $18.37 2.50
2009-09-30 43.05 $18.27 2.36
2009-06-30 39.84 $16.79 2.37
2009-03-31 36.56 $15.87 2.30
2008-12-31 41.24 $15.35 2.69
2008-09-30 47.38 $16.45 2.88
2008-06-30 43.72 $16.61 2.63
2008-03-31 43.78 $16.19 2.70
2007-12-31 44.72 $15.25 2.93
2007-09-30 43.78 $15.17 2.89
2007-06-30 40.78 $14.90 2.74
2007-03-31 39.62 $14.14 2.80
2006-12-31 43.16 $13.59 3.18
2006-09-30 42.21 $13.97 3.02
2006-06-30 38.73 $13.89 2.79
2006-03-31 38.04 $13.83 2.75
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $431.227B $82.584B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $311.243B 0.00
Pfizer (PFE) United States $247.816B 14.08
Novo Nordisk (NVO) Denmark $234.679B 32.57
Eli Lilly (LLY) United States $222.149B 28.85
AbbVie (ABBV) United States $188.027B 9.01
Novartis AG (NVS) Switzerland $185.202B 13.75
Merck (MRK) United States $182.082B 12.47
AstraZeneca (AZN) United Kingdom $181.247B 25.77
Sanofi (SNY) $120.758B 13.30
GlaxoSmithKline (GSK) United Kingdom $104.607B 13.13
Bayer (BAYRY) Germany $52.049B 7.01
H Lundbeck (HLUYY) Denmark $5.375B 10.30
Innoviva (INVA) United States $1.103B 5.92